NCT04184258View on ClinicalTrials.gov

Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL

Pooled mesenchymal stem cell

Pooled allogenic mesenchymal stem cell derived from olfactory mucosa

OTHER

Standard treatment according to the Clinical protocols

Standard SLE treatment according to the Clinical protocols approved by the Ministry of healthcare of Republic of Belarus

Trial Locations (1)

220072

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk

All Listed Sponsors
collaborator

Belarusian State Medical University

OTHER

lead

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

OTHER_GOV

NCT04184258 - Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells | Biotech Hunter | Biotech Hunter